Sleep-Related Eating Disorder in Two Patients with Early-Onset Parkinson’s Disease

Neto, Manoel Alves Sobreira; Pereira, Marcelo de Souza Fernandes; Sobreira, Emmanuelle Silva Tavares; Chagas, Marcos Hortes Nisihara; Rodrigues, Guilherme; Fernandes, Regina Maria França; Tumas, Vítor; Schenck, Carlos H.; Éckeli, Alan Luiz

doi:10.1159/000329577

Cited by 15 publications

(10 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The other was typical for NREM sleep parasomnia, during which patients had sleep-talking or sleepwalking, could not be easily aroused, and of which they had poor recollection [8]. Additional unusual case reports of POD, including a 37 year old man with RBD, sleepwalking, and sexsomnia [32], and two Parkinson disease-related RBD patients (age 28 and 37) with SRED [33], suggest some subtypes of POD may occur more frequently in early-onset RBD than others. Idiopathic POD and POD variants—including SRED, sexsomnia, rhythmic movement disorder, status dissociatus, or those symptomatic of central nervous system lesions, were recently reviewed, along with an additional discussion of cumulative literature on POD and RBD in younger adults [34].…”

Section: Parasomnia Overlap Disordermentioning

confidence: 99%

Rapid eye movement sleep behavior disorder in adults younger than 50 years of age

Ju¹

2013

Sleep Medicine

View full text Add to dashboard Cite

Rapid eye movement (REM) sleep behavior disorder (RBD) occurring prior to age 50 is termed early-onset RBD. Early-onset RBD comprises a substantial minority of cases, and demonstrates the differences in demographics, comorbidities, and clinical considerations from previously described typical RBD with onset >50 years. The world literature on RBD is reviewed with specific focus on features that distinguish early-onset RBD, including more gender parity, increased proportion of idiopathic cases, increased proportion of cases associated with narcolepsy, parasomnia overlap disorder, antidepressants, and possibly autoimmune disorders, and clinical presentation.

show abstract

Section: Parasomnia Overlap Disordermentioning

confidence: 99%

Rapid eye movement sleep behavior disorder in adults younger than 50 years of age

Ju¹

2013

Sleep Medicine

View full text Add to dashboard Cite

show abstract

“…As with depression and anxiety disorders, sleep disorders are also reported to increase the risk of development of PD in the later life. [ 136 137 138 139 140 141 ] A longitudinal population-based prospective study reported increased risk of PD in patients with EDS. This risk persists after controlling for various confounders like mid-life cigarette smoking and coffee drinking, bowel movement frequency, cognitive functions, depressed mood, and insomnia.…”

Section: Introductionmentioning

confidence: 99%

Psychiatric aspects of Parkinson’s disease

Grover

Somaiya

Kumar

et al. 2015

Journal of Neurosciences in Rural Practice

View full text Add to dashboard Cite

Parkinson's disease (PD) is essentially characterized by the motor symptoms in the form of resting tremor, rigidity and bradykinesia. However, over the years it has been recognized that motor symptoms are just the “tip of the iceberg” of clinical manifestations of PD. Besides motor symptoms, PD characterized by many non-motor symptoms, which include cognitive decline, psychiatric disturbances (depression, psychosis and impulse control), sleep difficulties, autonomic failures (gastrointestinal, cardiovascular, urinary, thermoregulation) and pain syndrome. This review evaluates the various aspects of psychiatric disorders including cognitive decline and sleep disturbances in patients with PD. The prevalence rate of various psychiatric disorders is high in patients with PD. In terms of risk factors, various demographic, clinical and treatment-related variables have been shown to be associated with higher risk of development of psychiatric morbidity. Evidence also suggests that the presence of psychiatric morbidity is associated with poorer outcome. Randomized controlled trials, evaluating the various pharmacological and non-pharmacological treatments for management of psychiatric morbidity in patients with PD are meager. Available evidence suggests that tricyclic antidepressants like desipramine and nortriptyline are efficacious for management of depression. Among the antipsychotics, clozapine is considered to be the best choice for management of psychosis in patients with PD. Among the various cognitive enhancers, evidence suggest efficacy of rivastigmine in management of dementia in patients with PD. To conclude, this review suggests that psychiatric morbidity is highly prevalent in patients with PD. Hence, a multidisciplinary approach must be followed to improve the overall outcome of PD. Further studies are required to evaluate the efficacy of various other measures for management of psychiatric morbidity in patients with PD.

show abstract

“…Parkinson’s disease (PD) was considered a possible trigger for SRED behaviors. In two patients with early-onset PD, a 28-year-old male and a 37-year-old male, SRED was confirmed by audio-video polysomnography ( 87 ). In the first patient, besides SRED, episodes of confusional arousals during N3 sleep were recorded, while in the second case, OSA, NES, and RBD were present as comorbidities.…”

Section: Resultsmentioning

confidence: 99%

Current evidence and future perspectives in the exploration of sleep-related eating disorder–a systematic literature review

Vasiliu

2024

Front. Psychiatry

View full text Add to dashboard Cite

Sleep-related eating disorder (SRED) is a non-REM parasomnia with potentially significant negative effects on general health (dangerous activities during night eating episodes, obesity, or metabolic syndrome, for example). Although the history of SRED encompasses more than six decades, public awareness and even the awareness of the mental health specialists of this disorder is very limited, a phenomenon that hinders the development of research in this field. Therefore, a systematic review based on PRISMA 2020 guidelines explored the available evidence for SRED found in four electronic databases (PubMed, Cochrane Collaboration, Google Scholar, and Clarivate/Web of Science). A number of 94 primary and secondary reports were retrieved, investigating aspects regarding the risk factors, epidemiology, clinical data and differential diagnosis, epidemiology, structured evaluation, and treatment of SRED. Based on the results of these reports, Z-drugs, but also certain benzodiazepines, antidepressants, antipsychotics, and psychostimulants may trigger the onset of SRED. Psychiatric and neurologic disorders have also been associated with SRED, either as risk factors or comorbid conditions. Cerebral glucose metabolism dysfunctions, neurotransmitter dysfunctions, and genetic factors have been invoked as pathogenetic contributors. Structured assessment of SRED is possible, but there is a dearth of instruments dedicated to this purpose. Data on the prevalence and treatment of SRED exist, but good-quality epidemiological studies and clinical trials are still missing. In conclusion, future research is expected to address the shortcomings of SRED exploration by creating the conditions for better quality and larger group clinical research. The need for such investigation is granted by the importance of this pathology and its negative functional consequences.

show abstract

Sleep-Related Eating Disorder in Two Patients with Early-Onset Parkinson’s Disease

Cited by 15 publications

References 20 publications

Rapid eye movement sleep behavior disorder in adults younger than 50 years of age

Rapid eye movement sleep behavior disorder in adults younger than 50 years of age

Psychiatric aspects of Parkinson’s disease

Current evidence and future perspectives in the exploration of sleep-related eating disorder–a systematic literature review

Contact Info

Product

Resources

About